Intravenous Administration of Recombinant Human IL-10 Suppresses the Development of Anti–Thy 1–Induced Glomerulosclerosis in Rats

References

1. 1.↵
   1. Lee S.,
   2. Lee S.,
   3. Sharma K.

   The pathogenesis of fibrosis and renal disease in scleroderma: recent insights from glomerulosclerosis. Curr. Rheumatol. Rep. 2004, 6 (2), 141–148.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Hodson E. M.,
   2. Alexander S. I.

   Evaluation and management of steroid-sensitive nephritic syndrome. Curr. Opin. Pediatr. 2008, 20, 145–50.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Brockman M. A.,
   2. Kwon D. S.,
   3. Tighe D. P.,
   4. Pavlik D. F.,
   5. Rosato P. C.,
   6. Sela J.,
   7. Porichis F.,
   8. Le Gall S.,
   9. Waring M. T.,
   10. Moss K.,
   11. Jessen H.,
   12. Pereyra F.,
   13. Kavanagh D. G.,
   14. Walker B. D.,
   15. Kaufmann D. E.

   IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009, 114 (2), 346–356.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Schreiber S.,
   2. et al

   . Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Gastroenterology 2000, 119 (6), 1461.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Friedrich M.,
   2. Docke W. D.,
   3. Klein A.,
   4. Philipp S.,
   5. Volk H. D.,
   6. Sterry W.,
   7. Asadullah K.

   Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in psoriasis. J. Invest. Dermatol. 2002, 118 (4), 672.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Beamer G. L.,
   2. Flaherty D. K.,
   3. Assogba B. D.,
   4. Stromberg P.,
   5. Gonzalez-Juarrero M.,
   6. de Waal Malefyt R.,
   7. Vesosky B.,
   8. Turner J.

   Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J. Immunol. 2008, 181 (8), 5545.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. El-Shemi A. G.,
   2. Fujinaka H.,
   3. Matsuki A.,
   4. Kamiie J.,
   5. Kovalenko P.,
   6. Qu Z.,
   7. Bilim V.,
   8. Nishimoto G.,
   9. Yaoita E.,
   10. Yoshida Y.,
   11. Anegon I.,
   12. Yamamoto T.

   Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer. Kidney Int. 2004, 65 (4), 1280.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Mu W.,
   2. et al

   . IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J. Am. Soc. Nephrol. 2005, 16 (12), 3651.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Rachmawati H.,
   2. Beljaars L.,
   3. Reker-Smit C.,
   4. van Loenen-Weemaes A. M.,
   5. Hagens W. I.,
   6. Meijer D. K. F.,
   7. Poelstra K.

   Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 following intravenous administration in rats with extensive liver fibrosis. Pharm. Res. 2004, 21 (11), 2072.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Bagchus W. M.,
    2. Hoedemaeker P. J.,
    3. Rozing J.,
    4. Bakker W. W.

    Acute glomerulonephritis after intravenous injection of monoclonal anti-thymocyte antibodies in the rat. Immunol. Lett. 1986, 12 (2–3), 109.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Poelstra K.,
    2. Hardonk M. J.,
    3. Koudstaal J.,
    4. Bakker W. W.

    Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int. 1990, 37 (6), 1500.

    OpenUrlPubMedWeb of Science
12. 12.↵
    1. Tsuboi Y.,
    2. Shankland S. J.,
    3. Grande J. P.,
    4. Walker H. J.,
    5. Johnson R. J.,
    6. Dousa T. P.

    Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV. J. Clin. Invest. 1996, 98 (2), 262.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Wada Y.,
    2. Morioka T.,
    3. Oyanagi-Tanaka Y.,
    4. Yao J.,
    5. Suzuki Y.,
    6. Gejyo F.,
    7. Arakawa M.,
    8. Oite T.

    Impairment of vascular regeneration precedes progressive glomerulosclerosis in Anti–Thy 1 glomerulonephritis. Kidney Int. 2002, 61 (2), 432.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Tomita M.,
    2. Koike H.,
    3. Han G. D.,
    4. Shimizu F.,
    5. Kawachi H.

    Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion. Clin. Exp. Nephrol. 2004, 8 (1), 17.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Makibayashi K.,
    2. Tatematsu M.,
    3. Hirata M.,
    4. Fukushima N.,
    5. Kusano K.,
    6. Ohashi S.,
    7. Abe H.,
    8. Kuze K.,
    9. Fukatsu A.,
    10. Kita T.,
    11. Doi T.

    A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am. J. Pathol. 2001, 158 (5), 1733.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Koshikawa M.,
    2. Mukoyama M.,
    3. Mori K.,
    4. Suganami T.,
    5. Sawai K.,
    6. Yoshioka T.,
    7. Nagae T.,
    8. Yokoi H.,
    9. Kawachi H.,
    10. Shimizu F.,
    11. Sugawara A.,
    12. Nakao K.

    Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J. Am. Soc. Nephrol. 2005, 16 (9), 2690.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Haas M.,
    2. de Zeeuw D.,
    3. Van Zanten A.,
    4. Meijer D. K. F.

    Quantification of renal low molecular-weight protein handling in the intact rat. Kidney Int. 1993, 43, 949–954.

    OpenUrlPubMed
18. 18.↵
    1. Sen N. P.,
    2. Donaldson B.

    Improved colorimetric method for determining nitrate and nitrate in foods. J. Assoc. Off. Anal. Chem. 1978, 61 (6): 1389–1394.

    OpenUrlPubMed
19. 19.↵
    1. Ishizuka S.,
    2. Cunard R.,
    3. Poucell-Hatton S.,
    4. Wead L.,
    5. Lortie M.,
    6. Thomson S. C.,
    7. Gabbai F. B.,
    8. Satriano J.,
    9. Blantz R. C.

    Agmatine inhibits cell proliferation and improves renal function in anti-thy-1 glomerulonephritis. J. Am. Soc. Nephrol. 2000, 11 (12), 2256.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Gomis-Ruth F. X.,
    2. Gohlke U.,
    3. Betz M.,
    4. Knauper V.,
    5. Murphy G.,
    6. Lopez-Otin C.,
    7. Bode W.

    The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. J. Mol. Biol. 1996, 264 (3), 556.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Schnaper H. W.,
    2. Kopp J. B.,
    3. Poncelet A. C.,
    4. Hubchak S. C.,
    5. Stetler-Stevenson W. G.,
    6. Klotman P. E.,
    7. Kleinman H. K.

    Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. J. Cell. Sci. 1996, 109 (Pt 10), 2521.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Atkins R. C.,
    2. Holdsworth S. R.,
    3. Glasgow E. F.,
    4. Matthews F. E.

    The macrophage in human rapidly progressive glomerulonephritis. Lancet 1976, 1 (7964), 830–832.

    OpenUrlPubMedWeb of Science
23. 23.↵
    1. Ma F. Y.,
    2. Flanc R. S.,
    3. Tesch G. H.,
    4. Bennett B. L.,
    5. Friedman G. C.,
    6. Nikolic-Paterson D. J.

    Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat. Lab Invest. 2009, 89 (4), 470.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Kaneko Y.,
    2. Shiozawa S.,
    3. Hora K.,
    4. Nakazawa K.

    Glomerulosclerosis develops in Thy-1 nephritis under persistent accumulation of macrophages. Pathol. Int. 2003, 53 (8), 507.

    OpenUrlPubMed
25. 25.↵
    1. Robertson T. E.,
    2. Nikolic-Paterson D. J.,
    3. Tesch G. H.,
    4. Foti R. A.,
    5. Atkins R. C.,
    6. Chadban S. J.

    Role of interleukin-10 in rat mesangioproliferative glomerulonephritis. Nephrology 2003, 8 (1), 33.

    OpenUrlPubMed
26. 26.↵
    1. Tesch G. H.,
    2. Lan H. Y.,
    3. Atkins R. C.,
    4. Nikolic-Paterson D. J.

    Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Am. J. Pathol. 1997, 151 (1), 141.

    OpenUrlPubMedWeb of Science
27. 27.↵
    1. Kaneko Y.,
    2. Nakazawa K.,
    3. Higuchi M.,
    4. Hora K.,
    5. Shigematsu H.

    Glomerular expression of alpha-smooth muscle actin reflects disease activity of IgA nephropathy. Pathol. Int. 2001, 51 (11), 833.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Hsu C. C.,
    2. Lai S. C.

    Matrix metalloproteinase-2, -9 and -13 are involved in fibronectin degradation of rat lung granulomatous fibrosis caused by Angiostrongylus cantonensis. Int. J. Exp. Pathol. 2007, 88 (6), 437.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Hernández Ríos M.,
    2. Sorsa T.,
    3. Obregón F.,
    4. Tervahartiala T.,
    5. Valenzuela M. A.,
    6. Pozo P.,
    7. Dutzan N.,
    8. Lesaffre E.,
    9. Molas M.,
    10. Gamonal J.

    Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade. J. Clin. Periodontol. 2009, 36 (12), 1011.

    OpenUrlCrossRefPubMed